MX2009008139A - Derivdos de 2-5a y su uso como agentes anti-cancer, antivirales y anti-parasitos. - Google Patents
Derivdos de 2-5a y su uso como agentes anti-cancer, antivirales y anti-parasitos.Info
- Publication number
- MX2009008139A MX2009008139A MX2009008139A MX2009008139A MX2009008139A MX 2009008139 A MX2009008139 A MX 2009008139A MX 2009008139 A MX2009008139 A MX 2009008139A MX 2009008139 A MX2009008139 A MX 2009008139A MX 2009008139 A MX2009008139 A MX 2009008139A
- Authority
- MX
- Mexico
- Prior art keywords
- analogs
- methods
- compounds
- relates
- ameliorating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Abstract
La presente invención es concerniente con los campos de química orgánica, química farmacéutica, bioquímica, biológica molecular y medicina. En particular, es concerniente con compuestos de Fórmula (I) que activa RNasaL y con el uso de los compuestos para tratar y/o mejorar una enfermedad o una condición, tal como una infección viral. (Fórmula I).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88758307P | 2007-01-31 | 2007-01-31 | |
PCT/US2008/052528 WO2008095040A2 (en) | 2007-01-31 | 2008-01-30 | 2-5a derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009008139A true MX2009008139A (es) | 2009-08-12 |
Family
ID=39674778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009008139A MX2009008139A (es) | 2007-01-31 | 2008-01-30 | Derivdos de 2-5a y su uso como agentes anti-cancer, antivirales y anti-parasitos. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20080207554A1 (es) |
EP (1) | EP2121719A2 (es) |
JP (1) | JP2010518015A (es) |
KR (1) | KR20100014878A (es) |
CN (1) | CN101652378A (es) |
AU (1) | AU2008210411A1 (es) |
CA (1) | CA2676822A1 (es) |
MX (1) | MX2009008139A (es) |
RU (1) | RU2009132512A (es) |
WO (1) | WO2008095040A2 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090181921A1 (en) * | 2007-12-21 | 2009-07-16 | Alios Biopharma Inc. | 2-5a analogs and their methods of use |
WO2010108135A1 (en) * | 2009-03-20 | 2010-09-23 | Alios Biopharma, Inc. | Protected nucleotide analogs |
US20100331397A1 (en) * | 2009-06-24 | 2010-12-30 | Alios Biopharma, Inc. | 2-5a analogs and their methods of use |
CA2812962C (en) | 2010-09-22 | 2020-03-31 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
KR20130110170A (ko) | 2010-09-22 | 2013-10-08 | 앨리오스 바이오파마 인크. | 치환된 뉴클레오타이드 유사체 |
WO2013096680A1 (en) | 2011-12-22 | 2013-06-27 | Alios Biopharma, Inc. | Substituted phosphorothioate nucleotide analogs |
ES2702060T3 (es) | 2011-12-22 | 2019-02-27 | Alios Biopharma Inc | Nucleósidos sustituidos, nucleótidos y sus análogos |
CN104321333A (zh) | 2012-03-21 | 2015-01-28 | 沃泰克斯药物股份有限公司 | 硫代氨基磷酸酯核苷酸前药的固体形式 |
US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
EP2827876A4 (en) | 2012-03-22 | 2015-10-28 | Alios Biopharma Inc | PHARMACEUTICAL COMBINATIONS WITH A THIONUCLEOTIDE ANALOG |
CA2871547C (en) | 2012-05-25 | 2021-05-25 | Janssen R&D Ireland | Uracyl spirooxetane nucleosides |
KR102168621B1 (ko) | 2012-12-21 | 2020-10-22 | 얀센 바이오파마, 인코퍼레이트. | 치환된 뉴클레오사이드, 뉴클레오타이드 및 그것의 유사체 |
AU2014250764A1 (en) | 2013-04-12 | 2015-10-29 | Achillion Pharmaceuticals, Inc. | Deuterated nucleoside prodrugs useful for treating HCV |
WO2015054465A1 (en) | 2013-10-11 | 2015-04-16 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
UA124966C2 (uk) | 2015-03-06 | 2021-12-22 | Атеа Фармасеутікалс, Інк. | <font face="Symbol">b</font>-D-2'-ДЕЗОКСИ-2'-<font face="Symbol">a</font>-ФТОР-2'-<font face="Symbol">b</font>-C-ЗАМІЩЕНІ-2-МОДИФІКОВАНІ-N<sup>6</sup>-ЗАМІЩЕНІ ПУРИНОВІ НУКЛЕОТИДИ ДЛЯ ЛІКУВАННЯ ВИКЛИКАНИХ HCV ЗАХВОРЮВАНЬ |
US10202412B2 (en) | 2016-07-08 | 2019-02-12 | Atea Pharmaceuticals, Inc. | β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections |
AU2017324939B2 (en) | 2016-09-07 | 2021-10-14 | Atea Pharmaceuticals, Inc. | 2'-substituted-N6-substituted purine nucleotides for RNA virus treatment |
IL295609B2 (en) | 2017-02-01 | 2023-11-01 | Atea Pharmaceuticals Inc | Nucleotide hemisulfate salt for the treatment of hepatitis C virus |
WO2019200005A1 (en) | 2018-04-10 | 2019-10-17 | Atea Pharmaceuticals, Inc. | Treatment of hcv infected patients with cirrhosis |
TWI794742B (zh) | 2020-02-18 | 2023-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
CA3216162A1 (en) | 2021-04-16 | 2022-10-20 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
CN113521099A (zh) * | 2021-09-10 | 2021-10-22 | 吉林大学第一医院 | 锌离子在抗肠道病毒ev-d68中的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI347948B (en) * | 2002-11-19 | 2011-09-01 | Sankyo Co | Novel 2',5'-oligoadenylic acid compositions |
-
2008
- 2008-01-30 CA CA002676822A patent/CA2676822A1/en not_active Abandoned
- 2008-01-30 JP JP2009548429A patent/JP2010518015A/ja not_active Withdrawn
- 2008-01-30 US US12/022,866 patent/US20080207554A1/en not_active Abandoned
- 2008-01-30 MX MX2009008139A patent/MX2009008139A/es unknown
- 2008-01-30 CN CN200880003717A patent/CN101652378A/zh active Pending
- 2008-01-30 AU AU2008210411A patent/AU2008210411A1/en not_active Abandoned
- 2008-01-30 KR KR1020097018078A patent/KR20100014878A/ko not_active Application Discontinuation
- 2008-01-30 WO PCT/US2008/052528 patent/WO2008095040A2/en active Application Filing
- 2008-01-30 RU RU2009132512/04A patent/RU2009132512A/ru not_active Application Discontinuation
- 2008-01-30 EP EP08728612A patent/EP2121719A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
KR20100014878A (ko) | 2010-02-11 |
CN101652378A (zh) | 2010-02-17 |
EP2121719A2 (en) | 2009-11-25 |
AU2008210411A1 (en) | 2008-08-07 |
WO2008095040A2 (en) | 2008-08-07 |
RU2009132512A (ru) | 2011-03-10 |
US20080207554A1 (en) | 2008-08-28 |
AU2008210411A2 (en) | 2009-08-27 |
JP2010518015A (ja) | 2010-05-27 |
WO2008095040A3 (en) | 2009-05-07 |
CA2676822A1 (en) | 2008-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009008139A (es) | Derivdos de 2-5a y su uso como agentes anti-cancer, antivirales y anti-parasitos. | |
WO2008134761A3 (en) | Modification of biological targeting groups for the treatment of cancer | |
TN2009000291A1 (en) | Inhibitors of mek | |
BR112012010270A2 (pt) | mentisulfonilmetano (msm) para tratamento de micro-organismos resistentes a fármaco | |
WO2011005595A3 (en) | 2-5a analogs and their methods of use | |
BR112012029975A2 (pt) | peptídeo como medicamento, em particular para o tratamento do câncer. | |
MX2009011064A (es) | Compuestos de azufre como inhibidores de la serina proteasa ns3 del virus de la hepatitis c. | |
WO2007138116A3 (de) | Pharmazeutische zusammensetzung zur behandlung von virusinfektionen und/oder tumorerkrankungen durch inhibition der proteinfaltung und des proteinabbaus | |
HK1123733A1 (en) | Viral hepatitis treatment | |
EA200901166A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr 119 | |
EA201070421A1 (ru) | Микрорибонуклеиновые кислоты | |
UA105390C2 (ru) | МОТИВЫ ХИМИЧЕСКИХ МОДИФИКАЦИЙ ДЛЯ ИНГИБИТОРОВ И МИМЕТИКОВ мкРНК | |
GEP20135964B (en) | Inhibitors of beta-secretase | |
BR112014005543A2 (pt) | sistema de descarte de medicação geral | |
WO2008127364A3 (en) | Antiviral compounds and use thereof | |
WO2008141308A3 (en) | Gene expression and pain | |
HK1125855A1 (en) | Use of oligouronates for treating mucus hyperviscosity | |
MX367131B (es) | Sales de xantilio 3,6-disustituidas. | |
TN2009000398A1 (en) | 5,6-dihydro-1h-pyridin-2-one compounds | |
WO2009106819A3 (en) | Biological materials and uses thereof | |
MX2012006206A (es) | Preparaciones combinacion comprendiendo exosomas y corticosteroide. | |
ATE492639T1 (de) | Multimer zur immunstimulation | |
MX2010004704A (es) | Inhibidores macrociclicos de la ns3 serina proteasa del virus de la hepatitis c. | |
CL2008000629A1 (es) | Compuestos macrociclicos derivados de 6-aril-4-mercapto-[1.3.5]triazina/[1.3]pirimidin-2-amina; composicion farmaceutica, utiles en el tratamiento del cancer. | |
HK1124084A1 (en) | Nucleic acid for treatment or prevention of immunodeficiency virus infection |